日本肝细胞癌的管理 - Suppr

Suppr

超能文献

Management of hepatocellular carcinoma in Japan.

作者信息

Okita Kiwamu

机构信息

Shimonoseki Kohsei Hospital, Kamishinchi-cho 3-3-8, Shimonoseki 750-5811, Japan.

出版信息

J Gastroenterol. 2006 Feb;41(2):100-6. doi: 10.1007/s00535-005-1763-0.

DOI:10.1007/s00535-005-1763-0

PMID:16568368

Abstract

摘要

相似文献

Management of hepatocellular carcinoma in Japan.

J Gastroenterol. 2006 Feb;41(2):100-6. doi: 10.1007/s00535-005-1763-0.

Liver cancer on the rise.

Ann Intern Med. 2005 Jun 21;142(12 Pt 1):1029-32. doi: 10.7326/0003-4819-142-12_part_1-200506210-00024.

State of the art: hepatocellular carcinoma.

Future Oncol. 2014 Nov;10(15 Suppl):1-6. doi: 10.2217/fon.14.215.

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Eur J Cancer. 2012 Mar;48(5):599-641. doi: 10.1016/j.ejca.2011.12.021.

Hepatocellular carcinoma.

Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):74-7. doi: 10.1054/bjoc.2001.1769.

World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.

J Gastrointestin Liver Dis. 2010 Sep;19(3):311-7.

[Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus].

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):615-8.

Hepatocellular carcinoma: current management.

Curr Probl Surg. 2010 Jan;47(1):10-67. doi: 10.1067/j.cpsurg.2009.09.003.

[Hepatoma].

Schweiz Med Wochenschr. 1979 Jun 23;109(25):946-9.

Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2008 May;19 Suppl 2:ii27-8. doi: 10.1093/annonc/mdn114.

引用本文的文献

Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.

Yonago Acta Med. 2023 Nov 7;66(4):422-431. doi: 10.33160/yam.2023.11.007. eCollection 2023 Nov.

Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study.

BMC Gastroenterol. 2022 Jun 2;22(1):275. doi: 10.1186/s12876-022-02359-x.

The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.

PLoS One. 2022 Jan 18;17(1):e0262675. doi: 10.1371/journal.pone.0262675. eCollection 2022.

Consensus on the secondary prevention of primary liver cancer.

Hepatol Int. 2021 Dec;15(6):1289-1300. doi: 10.1007/s12072-021-10259-7. Epub 2021 Nov 30.

Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib.

Intern Med. 2021;60(13):2047-2053. doi: 10.2169/internalmedicine.5870-20. Epub 2021 Jul 1.

Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma.

PLoS One. 2014 Jul 21;9(7):e103009. doi: 10.1371/journal.pone.0103009. eCollection 2014.

TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women.

Tumour Biol. 2014 Sep;35(9):8999-9007. doi: 10.1007/s13277-014-2170-z. Epub 2014 Jun 7.

Intraoperative ablation for small HCC not amenable for percutaneous radiofrequency ablation in Child A cirrhotic patients.

J Gastrointest Surg. 2013 Apr;17(4):712-8. doi: 10.1007/s11605-012-2085-1. Epub 2012 Nov 21.

Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents.

Oncol Lett. 2011 Jan;2(1):69-73. doi: 10.3892/ol.2010.196. Epub 2010 Oct 5.

CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.

Med Oncol. 2012 Dec;29(4):2771-9. doi: 10.1007/s12032-012-0189-9. Epub 2012 Feb 29.

本文引用的文献

Management of hepatocellular carcinoma.

Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.

Report of the 16th follow-up survey of primary liver cancer.

Hepatol Res. 2005 Jul;32(3):163-72. doi: 10.1016/j.hepres.2005.04.005. Epub 2005 Jul 18.

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

Gastroenterology. 2004 Dec;127(6):1714-23. doi: 10.1053/j.gastro.2004.09.003.

Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.

JAMA. 2004 Jul 21;292(3):358-61. doi: 10.1001/jama.292.3.358.

Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.

Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6.

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

J Gastroenterol. 2003;38(3):207-15. doi: 10.1007/s005350300038.

AGA technical review on nonalcoholic fatty liver disease.

Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572.

Update on nonalcoholic fatty liver disease.

J Clin Gastroenterol. 2002 Mar;34(3):255-62. doi: 10.1097/00004836-200203000-00013.

Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future.

Oncology. 2002;62 Suppl 1:8-17. doi: 10.1159/000048270.

Characteristics of hepatocellular carcinoma in Japan.

Oncology. 2002;62 Suppl 1:5-7. doi: 10.1159/000048269.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验